期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

HPV感染的子宫颈癌相关基因及基因治疗的研究进展 被引量：3

下载PDF
导出
摘要 子宫颈癌是妇女最常见的恶性肿瘤之一，目前已经在女性恶性肿瘤中排名第二，并呈年轻化趋势。据统计每年有近50万新发病例，而总体5年生存率在52％左右。子宫颈癌的手术治疗、放疗和化疗及新的治疗方式，在一定程度上提高了患者生存率，但治疗效果仍不能令人满意，
作者 罗飞 李志英
机构地区 三峡大学医学院 三峡大学仁和医院
出处 《肿瘤预防与治疗》 2010年第5期432-434,共3页 Journal of Cancer Control And Treatment
关键词 子宫颈癌 人乳头瘤病毒 相关基因 基因治疗
分类号 R737.33 [医药卫生—肿瘤] R730.58 [医药卫生—肿瘤]
  • 相关文献

参考文献23

  • 1Alvarez-Salas LM,Benitez-Hess ML,DiPaolo JA.Advances in the development of ribozymes and antisense oligodeoxynu-cleotides as antiviral agents for human papillomaviruses[J].Antivir Ther,2003,8(4):265-278.
  • 2孙建衡.子宫颈癌治疗的回顾与展望[J].中华肿瘤杂志,2006,28(2):159-160. 被引量：21
  • 3Choi YW,Kim YW,Bae SM,et al.Identification of differentially expressed genes using annealing control primer-based geneFishing in human squamous cell cervical carcinoma[J].Clinical Oncology,2007,19(5):308-318.
  • 4Oikawa K,Ohbayashi T,Kiyono T,et al.Expression of novel human gene,human wings apart-like(hWAPL),is associated with cervical carcinogenesis and tumor progression[J].Cancer Res,2004,64(10):3545-3549.
  • 5Oikawa K,Akiyoshi A,Tanaka M,et al.Expression of various types of alternatively spliced WAPL transcripts in human cervical epithelia[J].Gene,2008,423(1):57-62.
  • 6Ohbayashi T,Oikawa K,Nishida-Umehara C,et al.Unscheduled overexpression of human WAPL promoteschromosomal instability[J].Biochemical and Biophysical Research Communications,2007,356 (3):699-704.
  • 7Soto U,Denk C,Finzer P,et al.Genetic complementation to non-tumourigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition[J].Cancer,2000,86(6):811-817.
  • 8Talora C,Sgroi DC,Crum CP,et al.Specific down-modulation of Notch1 signalling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation[J].Genes Develop,2002,16(17):2252-2263.
  • 9Milde-Langosch K.The Fos family of transcription factors and their role in tumourigenesis[J].European Journal of Cancer,2005,41 (16):2449-2461.
  • 10Choo KB,Huanga CJ,Chen CM,et al.Jun-B oncogene aberrations in cervical cancer cell lines[J].Cancer Letters,1995,93(2):249-253.

二级参考文献22

  • 1Blachon S, Bellanger S, Demeret C et al. Nucleo-cytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis[ J]. J Biol Chem, 2005 ; 280(43) : 36088-36098.
  • 2Steller M A. Cervical cancer vaccines: progress and prospects [J].J Soc Gynecol Investing, 2002; 9 (5) : 254-264.
  • 3Govan V A, Williamson A L. Rabbits immunized with recombinant BCG expressing the cottontail rabbit papillomavims (CRPV) L2E7E2 genes induces regression of established papillomas[J]. Vires Res, 2007; 127 ( 1 ) : 43--48.
  • 4Brandsma J L, Shlyankevich M, Zelterman D et al. Therapeutic vaccination of rabbits with a ubiquitin-fused papillomavims E1, E2, E6 and E7 DNA vaccine[J]. Vaccine, 2007 ; 25 (33) :6158-6163.
  • 5De Jong A, van der Burg S H, Kwappenberg K Met al. Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects [ J ]. Cancer Res, 2002; 62 (2) : 472-479.
  • 6Liu B, Ye D, Song X et al. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent Anti-tumor immunity and antiangiogenesis [J].Vaccine, 2008; 26(10) : 1387-1396.
  • 7Gardai S J, McPhillips K A, Frasch S C et al. Cell-surface calreticulin ini- tiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte[J]. Cell,2005; 123(2) :321-334.
  • 8Obeid M, Tesniere A, Ghiringhelli F et al. Calreticulin exposure dictates the immunogenicity of cancer cell death[J]. Nat Med, 2007; 13( 1 ) : 54- 61.
  • 9Cricca M, Morselli-Labate A M, Venturoli S et al. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions [ J ]. Gynecol Oncol, 2007 ; 106 (3) : 549-557.
  • 10Hsieh C H, Kima T B, Hunga C F et al. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin [J]. Vaccine, 2004 ; 22(29-30) :3993-4001.

共引文献21

同被引文献32

  • 1Zhu, Hong,Yang, Zhi-Bin.Expression pattern of mda-7/IL-24 receptors in liver cancer cell lines[J].Hepatobiliary & Pancreatic Diseases International,2009,8(4):402-406. 被引量：5
  • 2张国楠.子宫颈癌的术前动脉化疗[J].实用妇产科杂志,2005,21(4):199-201. 被引量：24
  • 3Ngan HY, Cheung AN, Tam KF, et al. Human papilloma- virus-16/18 AS04-adjuvanted cervical cancer vaccine:im- munogenicity and safety in healthy Chinese women from Hong Kong [J]. Hong Kong Med J,2010, 16 (3): 171-179.
  • 4Ahmad AT, Haris Z, Brian M, et al. Phase I Trial of Car- boplatin and Etoposide in Combination with Panobinostat in Patients with Lung Cancer[ J]. Anticancer Res,2013, 33 (10) :4475-4481.
  • 5Theodore SJ, Catherine ET, Michael BJ, et al. Etoposide Selectively Ablates Activated T Cells To Control the Im- munoregulatory Disorder Hemophagoeytic Lymphohistiocy- tosis [ J ]. J Immuno1,2014,192 ( 1 ) : 84-91.
  • 6Mohar A, Mendivil MF. Epidemiology of cervical cancer [ J]. Cancer invest,2000,18(6) :584-590.
  • 7Sachiko K, Tomoyuki M, Masahide F, et al. Effect of P- Glycoprotein and Breast Cancer Resistance Protein Inhibi- tion on the Pharmacokinetics of Sunitinib in Rats [ J ]. Drug Metab Dispos,2013,41 (8) : 1592 - 1597.
  • 8Mittapalli RK, Vaidhyanathan S, Elmquist WF, et al. Im- pact of P-Glycoprotein ( ABCB1 ) and Breast Cancer Re- sistance Protein ( ABCG2 ) on the Brain Distribution of a Novel BRAF Inhibitor: Vemurafenib ( PLX4032 ) [ J ]. J Pharmacol Exp Ther,2012,342( 1 ) :33-40.
  • 9Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. [ J ]. Biochim Biophys Acta, 1976,455 ( 1 ) : 152-162.
  • 10Jurjen SL, Carola WD, Robert AW, et al. P-Glycopro- tein, Muhidrug-Resistance Associated Protein 2, Cyp3 a, and Carboxylesterase Affect the Oral Availability and Metabolism of Vinorelbine [ J ]. Mol Pharmacol, 2012,82 (4) :636 - 644.

引证文献3

二级引证文献5

肿瘤预防与治疗
2010年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部